Fujita Y, Yoshikuni Y, Sotomatsu T, Mori T, Ozaki T, Sempuku K, Ogino A, Kise M, Enomoto H
Research Laboratories, Nippon Shinyaku Co., Ltd., Kyoto, Japan.
Chem Pharm Bull (Tokyo). 1991 May;39(5):1193-8. doi: 10.1248/cpb.39.1193.
A series of N-phenyl-delta 8-dihydroabietamide analogs were prepared and tested for hypocholesterolemic activity. The effects of substituents of the phenyl moiety on the activities were quantitatively analyzed by using various substituent parameters. The activities were enhanced by the electron-donating effect of ortho and para substitutents and the bulkiness of ortho substituents. A combination of 2,6-dimethylaniline with resin acids other than delta 8-dihydroabietic acid produced lower activities than N-(2,6-dimethylphenyl)-delta 8-dihydroabietamide, abietane-type carboxamides being somewhat stronger than pimarane-type carboxamides. The conversion of the carboxamide group to other groups resulted in more or less of a decrease in activity, giving evidence that the carboxamide group is important to hypocholesterolemic activity.
制备了一系列N-苯基-δ8-二氢枞酰胺类似物,并测试其降胆固醇活性。通过使用各种取代基参数对苯基部分的取代基对活性的影响进行了定量分析。邻位和对位取代基的供电子效应以及邻位取代基的体积增大增强了活性。2,6-二甲基苯胺与除δ8-二氢枞酸以外的树脂酸组合产生的活性低于N-(2,6-二甲基苯基)-δ8-二氢枞酰胺,枞烷型羧酰胺比海松烷型羧酰胺稍强。将羧酰胺基团转化为其他基团导致活性或多或少降低,这表明羧酰胺基团对降胆固醇活性很重要。